APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biologics Development Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biologics Development Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 May 2026193 pages

Choose your research edition.

Industry ResearchBiologics Development Service Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologics Development Service Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biologics Development Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologics Development Service Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologics Development Service Market Analysis and Forecast 2026-2032249 pages · $4,950 USD

Market perspective

The global Biologics Development Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Biologics Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biologics Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologics Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biologics Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biologics Development Service include Meso Scale Discovery, Patheon, Immunologix, GenScript, Promega, Recibiopharm, Alcami Biologics, Leadgene Biomedical and Samsung Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Biologics Development Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biologics Development Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biologics Development Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biologics Development Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Biologics Development Service Segment by Company

Meso Scale Discovery

Patheon

Immunologix

GenScript

Promega

Recibiopharm

Alcami Biologics

Leadgene Biomedical

Samsung Biologics

Lonza

ImmunoGen

Seattle Genetics

Roche

Takeda

Biologics Development Service Segment by Type

Vaccine

Blood and Blood Components

Tissue and Recombinant Therapeutic Proteins

Others

Biologics Development Service Segment by Application

Tumor Treatment

Chronic Disease Treatment

Enzyme and Hormone Deficiencies

Others

Biologics Development Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologics Development Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologics Development Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologics Development Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biologics Development Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biologics Development Service industry.

Chapter 3: Detailed analysis of Biologics Development Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologics Development Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biologics Development Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Vaccine Table 3. Key Players of Blood and Blood Components Table 4. Key Players of Tissue and Recombinant Therapeutic Proteins Table 3. Key Players of Others Table 4. Global Biologics Development Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Tumor Treatment Table 6. Key Players of Chronic Disease Treatment Table 7. Key Players of Enzyme and Hormone Deficiencies Table 8. Key Players of Others Table 9. Global Biologics Development Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Biologics Development Service Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Biologics Development Service Market Share by Region (2021-2026) Table 12. Global Biologics Development Service Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Biologics Development Service Market Share by Region (2027-2032) Table 14. Biologics Development Service Industry Trends Table 15. Biologics Development Service Industry Drivers Table 16. Biologics Development Service Industry Opportunities and Challenges Table 17. Biologics Development Service Industry Restraints Table 18. Global Biologics Development Service Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Biologics Development Service Revenue Market Share by Company (2021-2026) Table 20. Global Biologics Development Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Biologics Development Service Key Company Head Office and Area Served Table 22. Global Biologics Development Service Company, Product Type & Application Table 23. Global Biologics Development Service Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Biologics Development Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Biologics Development Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Biologics Development Service Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Biologics Development Service Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Biologics Development Service Revenue Market Share by Type (2021-2026) Table 30. Global Biologics Development Service Revenue Market Share by Type (2027-2032) Table 31. Global Biologics Development Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Biologics Development Service Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Biologics Development Service Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Biologics Development Service Revenue Market Share by Application (2021-2026) Table 35. Global Biologics Development Service Revenue Market Share by Application (2027-2032) Table 36. Meso Scale Discovery Company Information Table 37. Meso Scale Discovery Business Overview Table 38. Meso Scale Discovery Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Meso Scale Discovery Biologics Development Service Product Portfolio Table 40. Meso Scale Discovery Recent Development Table 41. Patheon Company Information Table 42. Patheon Business Overview Table 43. Patheon Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Patheon Biologics Development Service Product Portfolio Table 45. Patheon Recent Development Table 46. Immunologix Company Information Table 47. Immunologix Business Overview Table 48. Immunologix Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Immunologix Biologics Development Service Product Portfolio Table 50. Immunologix Recent Development Table 51. GenScript Company Information Table 52. GenScript Business Overview Table 53. GenScript Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. GenScript Biologics Development Service Product Portfolio Table 55. GenScript Recent Development Table 56. Promega Company Information Table 57. Promega Business Overview Table 58. Promega Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Promega Biologics Development Service Product Portfolio Table 60. Promega Recent Development Table 61. Recibiopharm Company Information Table 62. Recibiopharm Business Overview Table 63. Recibiopharm Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Recibiopharm Biologics Development Service Product Portfolio Table 65. Recibiopharm Recent Development Table 66. Alcami Biologics Company Information Table 67. Alcami Biologics Business Overview Table 68. Alcami Biologics Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Alcami Biologics Biologics Development Service Product Portfolio Table 70. Alcami Biologics Recent Development Table 71. Leadgene Biomedical Company Information Table 72. Leadgene Biomedical Business Overview Table 73. Leadgene Biomedical Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Leadgene Biomedical Biologics Development Service Product Portfolio Table 75. Leadgene Biomedical Recent Development Table 76. Samsung Biologics Company Information Table 77. Samsung Biologics Business Overview Table 78. Samsung Biologics Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Samsung Biologics Biologics Development Service Product Portfolio Table 80. Samsung Biologics Recent Development Table 81. Lonza Company Information Table 82. Lonza Business Overview Table 83. Lonza Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Lonza Biologics Development Service Product Portfolio Table 85. Lonza Recent Development Table 86. ImmunoGen Company Information Table 87. ImmunoGen Business Overview Table 88. ImmunoGen Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. ImmunoGen Biologics Development Service Product Portfolio Table 90. ImmunoGen Recent Development Table 91. Seattle Genetics Company Information Table 92. Seattle Genetics Business Overview Table 93. Seattle Genetics Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Seattle Genetics Biologics Development Service Product Portfolio Table 95. Seattle Genetics Recent Development Table 96. Roche Company Information Table 97. Roche Business Overview Table 98. Roche Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Roche Biologics Development Service Product Portfolio Table 100. Roche Recent Development Table 101. Takeda Company Information Table 102. Takeda Business Overview Table 103. Takeda Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Takeda Biologics Development Service Product Portfolio Table 105. Takeda Recent Development Table 106. North America Biologics Development Service Market Size by Type (2021-2026) & (US$ Million) Table 107. North America Biologics Development Service Market Size by Type (2027-2032) & (US$ Million) Table 108. North America Biologics Development Service Market Size by Application (2021-2026) & (US$ Million) Table 109. North America Biologics Development Service Market Size by Application (2027-2032) & (US$ Million) Table 110. North America Biologics Development Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Biologics Development Service Market Size by Country (2021-2026) Table 112. North America Biologics Development Service Market Size by Country (2027-2032) Table 113. Europe Biologics Development Service Market Size by Type (2021-2026) & (US$ Million) Table 114. Europe Biologics Development Service Market Size by Type (2027-2032) & (US$ Million) Table 115. Europe Biologics Development Service Market Size by Application (2021-2026) & (US$ Million) Table 116. Europe Biologics Development Service Market Size by Application (2027-2032) & (US$ Million) Table 117. Europe Biologics Development Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Biologics Development Service Market Size by Country (2021-2026) Table 119. Europe Biologics Development Service Market Size by Country (2027-2032) Table 120. China Biologics Development Service Market Size by Type (2021-2026) & (US$ Million) Table 121. China Biologics Development Service Market Size by Type (2027-2032) & (US$ Million) Table 122. China Biologics Development Service Market Size by Application (2021-2026) & (US$ Million) Table 123. China Biologics Development Service Market Size by Application (2027-2032) & (US$ Million) Table 124. Asia Biologics Development Service Market Size by Type (2021-2026) & (US$ Million) Table 125. Asia Biologics Development Service Market Size by Type (2027-2032) & (US$ Million) Table 126. Asia Biologics Development Service Market Size by Application (2021-2026) & (US$ Million) Table 127. Asia Biologics Development Service Market Size by Application (2027-2032) & (US$ Million) Table 128. Asia Biologics Development Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Asia Biologics Development Service Market Size by Country (2021-2026) Table 130. Asia Biologics Development Service Market Size by Country (2027-2032) Table 131. South America, Middle East & Africa Biologics Development Service Market Size by Type (2021-2026) & (US$ Million) Table 132. South America, Middle East & Africa Biologics Development Service Market Size by Type (2027-2032) & (US$ Million) Table 133. South America, Middle East & Africa Biologics Development Service Market Size by Application (2021-2026) & (US$ Million) Table 134. South America, Middle East & Africa Biologics Development Service Market Size by Application (2027-2032) & (US$ Million) Table 135. South America, Middle East & Africa Biologics Development Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. South America, Middle East & Africa Biologics Development Service Market Size by Country (2021-2026) Table 137. South America, Middle East & Africa Biologics Development Service Market Size by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Biologics Development Service Product Image Figure 2. Global Biologics Development Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Biologics Development Service Market Share by Type: 2025 VS 2032 Figure 4. Vaccine Image Figure 5. Blood and Blood Components Image Figure 6. Tissue and Recombinant Therapeutic Proteins Image Figure 7. Others Image Figure 8. Global Biologics Development Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Biologics Development Service Market Share by Application: 2025 VS 2032 Figure 10. Tumor Treatment Image Figure 11. Chronic Disease Treatment Image Figure 12. Enzyme and Hormone Deficiencies Image Figure 13. Others Image Figure 14. Global Biologics Development Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 16. Global Biologics Development Service Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Biologics Development Service Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Biologics Development Service Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Biologics Development Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Biologics Development Service Revenue Market Share by Type (2021-2032) Figure 23. Global Biologics Development Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Biologics Development Service Revenue Market Share by Application (2021-2032) Figure 25. North America Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 26. North America Biologics Development Service Market Share by Type (2021-2032) Figure 27. North America Biologics Development Service Market Share by Application (2021-2032) Figure 28. North America Biologics Development Service Market Share by Country (2021-2032) Figure 29. United States Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 30. Canada Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 32. Europe Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 33. Europe Biologics Development Service Market Share by Type (2021-2032) Figure 34. Europe Biologics Development Service Market Share by Application (2021-2032) Figure 35. Europe Biologics Development Service Market Share by Country (2021-2032) Figure 36. Germany Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 37. France Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 39. Italy Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 40. Russia Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 42. China Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 43. China Biologics Development Service Market Share by Type (2021-2032) Figure 44. China Biologics Development Service Market Share by Application (2021-2032) Figure 45. Asia Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 46. Asia Biologics Development Service Market Share by Type (2021-2032) Figure 47. Asia Biologics Development Service Market Share by Application (2021-2032) Figure 48. Asia Biologics Development Service Market Share by Country (2021-2032) Figure 49. Japan Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 53. India Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 54. Australia Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Biologics Development Service Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Biologics Development Service Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Biologics Development Service Market Share by Country (2021-2032) Figure 59. Brazil Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 64. UAE Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 66. Chile Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccine
  • Blood and Blood Components
  • Tissue and Recombinant Therapeutic Proteins
  • Others
Applications
  • Tumor Treatment
  • Chronic Disease Treatment
  • Enzyme and Hormone Deficiencies
  • Others
Companies covered
  • Meso Scale Discovery
  • Patheon
  • Immunologix
  • GenScript
  • Promega
  • Recibiopharm
  • Alcami Biologics
  • Leadgene Biomedical
  • Samsung Biologics
  • Lonza
  • ImmunoGen
  • Seattle Genetics
  • Roche
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Biologics Development Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Vaccine
  5. 1.2.3 Blood and Blood Components
  6. 1.2.4 Tissue and Recombinant Therapeutic Proteins
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Biologics Development Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Tumor Treatment
  11. 1.3.3 Chronic Disease Treatment
  12. 1.3.4 Enzyme and Hormone Deficiencies
  13. 1.3.5 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Biologics Development Service Growth Trends by Region
  16. 1.5.1 Global Biologics Development Service Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Biologics Development Service Market Size by Region (2021-2026)
  18. 1.5.3 Biologics Development Service Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Biologics Development Service Market Dynamics
  1. 2.1 Biologics Development Service Industry Trends
  2. 2.2 Biologics Development Service Industry Drivers
  3. 2.3 Biologics Development Service Industry Opportunities and Challenges
  4. 2.4 Biologics Development Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Biologics Development Service Revenue by Company (2021-2026)
  2. 3.2 Global Biologics Development Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Biologics Development Service Key Company Head office and Area Served
  4. 3.4 Global Biologics Development Service Company, Product Type & Application
  5. 3.5 Global Biologics Development Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Biologics Development Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Biologics Development Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Biologics Development Service Tier 1, Tier 2, and Tier 3
4 Biologics Development Service Market by Type
  1. 4.1 Global Biologics Development Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Biologics Development Service Market Size by Type (2021-2032)
  3. 4.3 Global Biologics Development Service Market Size Share by Type (2021-2032)
5 Biologics Development Service Market by Application
  1. 5.1 Global Biologics Development Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Biologics Development Service Market Size by Application (2021-2032)
  3. 5.3 Global Biologics Development Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Meso Scale Discovery
  2. 6.1.1 Meso Scale Discovery Company Information
  3. 6.1.2 Meso Scale Discovery Business Overview
  4. 6.1.3 Meso Scale Discovery Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Meso Scale Discovery Biologics Development Service Product Portfolio
  6. 6.1.5 Meso Scale Discovery Recent Developments
  7. 6.2 Patheon
  8. 6.2.1 Patheon Company Information
  9. 6.2.2 Patheon Business Overview
  10. 6.2.3 Patheon Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Patheon Biologics Development Service Product Portfolio
  12. 6.2.5 Patheon Recent Developments
  13. 6.3 Immunologix
  14. 6.3.1 Immunologix Company Information
  15. 6.3.2 Immunologix Business Overview
  16. 6.3.3 Immunologix Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Immunologix Biologics Development Service Product Portfolio
  18. 6.3.5 Immunologix Recent Developments
  19. 6.4 GenScript
  20. 6.4.1 GenScript Company Information
  21. 6.4.2 GenScript Business Overview
  22. 6.4.3 GenScript Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 GenScript Biologics Development Service Product Portfolio
  24. 6.4.5 GenScript Recent Developments
  25. 6.5 Promega
  26. 6.5.1 Promega Company Information
  27. 6.5.2 Promega Business Overview
  28. 6.5.3 Promega Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Promega Biologics Development Service Product Portfolio
  30. 6.5.5 Promega Recent Developments
  31. 6.6 Recibiopharm
  32. 6.6.1 Recibiopharm Company Information
  33. 6.6.2 Recibiopharm Business Overview
  34. 6.6.3 Recibiopharm Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Recibiopharm Biologics Development Service Product Portfolio
  36. 6.6.5 Recibiopharm Recent Developments
  37. 6.7 Alcami Biologics
  38. 6.7.1 Alcami Biologics Company Information
  39. 6.7.2 Alcami Biologics Business Overview
  40. 6.7.3 Alcami Biologics Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Alcami Biologics Biologics Development Service Product Portfolio
  42. 6.7.5 Alcami Biologics Recent Developments
  43. 6.8 Leadgene Biomedical
  44. 6.8.1 Leadgene Biomedical Company Information
  45. 6.8.2 Leadgene Biomedical Business Overview
  46. 6.8.3 Leadgene Biomedical Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Leadgene Biomedical Biologics Development Service Product Portfolio
  48. 6.8.5 Leadgene Biomedical Recent Developments
  49. 6.9 Samsung Biologics
  50. 6.9.1 Samsung Biologics Company Information
  51. 6.9.2 Samsung Biologics Business Overview
  52. 6.9.3 Samsung Biologics Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Samsung Biologics Biologics Development Service Product Portfolio
  54. 6.9.5 Samsung Biologics Recent Developments
  55. 6.10 Lonza
  56. 6.10.1 Lonza Company Information
  57. 6.10.2 Lonza Business Overview
  58. 6.10.3 Lonza Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Lonza Biologics Development Service Product Portfolio
  60. 6.10.5 Lonza Recent Developments
  61. 6.11 ImmunoGen
  62. 6.11.1 ImmunoGen Company Information
  63. 6.11.2 ImmunoGen Business Overview
  64. 6.11.3 ImmunoGen Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 ImmunoGen Biologics Development Service Product Portfolio
  66. 6.11.5 ImmunoGen Recent Developments
  67. 6.12 Seattle Genetics
  68. 6.12.1 Seattle Genetics Company Information
  69. 6.12.2 Seattle Genetics Business Overview
  70. 6.12.3 Seattle Genetics Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Seattle Genetics Biologics Development Service Product Portfolio
  72. 6.12.5 Seattle Genetics Recent Developments
  73. 6.13 Roche
  74. 6.13.1 Roche Company Information
  75. 6.13.2 Roche Business Overview
  76. 6.13.3 Roche Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Roche Biologics Development Service Product Portfolio
  78. 6.13.5 Roche Recent Developments
  79. 6.14 Takeda
  80. 6.14.1 Takeda Company Information
  81. 6.14.2 Takeda Business Overview
  82. 6.14.3 Takeda Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Takeda Biologics Development Service Product Portfolio
  84. 6.14.5 Takeda Recent Developments
7 North America
  1. 7.1 North America Biologics Development Service Market Size (2021-2032)
  2. 7.2 North America Biologics Development Service Market Size by Type
  3. 7.2.1 North America Biologics Development Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Biologics Development Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Biologics Development Service Market Share by Type (2021-2032)
  6. 7.3 North America Biologics Development Service Market Size by Application
  7. 7.3.1 North America Biologics Development Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Biologics Development Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Biologics Development Service Market Share by Application (2021-2032)
  10. 7.4 North America Biologics Development Service Market Size by Country
  11. 7.4.1 North America Biologics Development Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Biologics Development Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Biologics Development Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Biologics Development Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Biologics Development Service Market Size (2021-2032)
  2. 8.2 Europe Biologics Development Service Market Size by Type
  3. 8.2.1 Europe Biologics Development Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Biologics Development Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Biologics Development Service Market Share by Type (2021-2032)
  6. 8.3 Europe Biologics Development Service Market Size by Application
  7. 8.3.1 Europe Biologics Development Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Biologics Development Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Biologics Development Service Market Share by Application (2021-2032)
  10. 8.4 Europe Biologics Development Service Market Size by Country
  11. 8.4.1 Europe Biologics Development Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Biologics Development Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Biologics Development Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Biologics Development Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Biologics Development Service Market Size (2021-2032)
  2. 9.2 China Biologics Development Service Market Size by Type
  3. 9.2.1 China Biologics Development Service Market Size by Type (2021-2026)
  4. 9.2.2 China Biologics Development Service Market Size by Type (2027-2032)
  5. 9.2.3 China Biologics Development Service Market Share by Type (2021-2032)
  6. 9.3 China Biologics Development Service Market Size by Application
  7. 9.3.1 China Biologics Development Service Market Size by Application (2021-2026)
  8. 9.3.2 China Biologics Development Service Market Size by Application (2027-2032)
  9. 9.3.3 China Biologics Development Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Biologics Development Service Market Size (2021-2032)
  2. 10.2 Asia Biologics Development Service Market Size by Type
  3. 10.2.1 Asia Biologics Development Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Biologics Development Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Biologics Development Service Market Share by Type (2021-2032)
  6. 10.3 Asia Biologics Development Service Market Size by Application
  7. 10.3.1 Asia Biologics Development Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Biologics Development Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Biologics Development Service Market Share by Application (2021-2032)
  10. 10.4 Asia Biologics Development Service Market Size by Country
  11. 10.4.1 Asia Biologics Development Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Biologics Development Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Biologics Development Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Biologics Development Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Biologics Development Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Biologics Development Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Biologics Development Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Biologics Development Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Biologics Development Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Biologics Development Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Biologics Development Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Biologics Development Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Biologics Development Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Biologics Development Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Biologics Development Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Biologics Development Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Biologics Development Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Biologics Development Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst